Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05026632
PHASE1/PHASE2
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Sponsor: Nacuity Pharmaceuticals, Inc.
View on ClinicalTrials.gov
Summary
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Official title: Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-01-27
Completion Date
2026-04
Last Updated
2025-12-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
NPI-002 Intravitreal Implant
Implant inserted during vitrectomy.
Locations (1)
Royal Adelaide Hospital
Adelaide, Australia